ASXL3 gene mutations inhibit cell proliferation and promote cell apoptosis in mouse cardiomyocytes by upregulating lncRNA NONMMUT063967.2
Congenital heart disease (CHD) is a serious condition with unknown etiology. In a recent study, a compound heterozygous mutation (c.3526C > T [p.Arg1176Trp] and c.4643A > G [p.Asp1548Gly]) in the ASXL3 gene was identified, which is associated with CHD. This mutation was overexpressed in HL-1 m...
Main Authors: | Zequn Liu, Yanmin Jiang, Fu Fang, Ru Li, Jin Han, Xin Yang, Qiong Deng, Lu-Shan Li, Ting-ying Lei, Dong-Zhi Li, Can Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580823000869 |
Similar Items
-
Examining the neurodevelopmental and motor phenotypes of Bohring-Opitz syndrome (ASXL1) and Bainbridge-Ropers syndrome (ASXL3)
by: Maya C. Ayoub, et al.
Published: (2023-11-01) -
Quantitative proteomics analysis revealed the potential role of lncRNA Ftx in cardiomyocytes
by: Xiangfei Sun, et al.
Published: (2023-01-01) -
ASXL gain-of-function truncation mutants: defective and dysregulated forms of a natural ribosomal frameshifting product?
by: Adam M. Dinan, et al.
Published: (2017-10-01) -
LncRNA CRNDE inhibits cardiomyocytes apoptosis by YAP1 in myocardial ischaemia/reperfusion injury
by: Xiaohua Zhu, et al.
Published: (2021-05-01) -
Mutations in <it>ASXL1 </it>are associated with poor prognosis across the spectrum of malignant myeloid diseases
by: Gelsi-Boyer Véronique, et al.
Published: (2012-03-01)